Eris Lifesciences Ltd(BSE:ERIS)

{{price.price}} INR

{{price.change}}%

：{{price.high}}	：7297	：6.44%	：30.4936
：{{price.low}}	：10115831	：45.46%	：1909
：{{price.open}}	：-2.21%	：13.86%	：1130
：{{price.close}}	：0.01	：14372200000%	：188033796111

-5.83	-10.56	-12.93	-21.38
-7.86	13.17	124.7	126.52
3.26	3.97	2.47	7297
14979	62414	符号详情：1天涨跌率 -2.21	-4.47
-7.81	-31	-64	-117
1417	1443	1504	5038.6
4224.43	9005.98	6961.8	1.62
0.01	-0.56	0.05	1.62
0.29	0.41	1356	1356
1356	341	1130	1561
1737	1887	1909	1909
25.85	30.52	3518400000	4156500000
3834700000	13013500000	14372200000	9.63
8.82	25.82	30.49	7695800000
28936400000	29981600000
			7693800000
	23140900000	35034800000	9119700000
697500000	1997400000	747500000	2278300000
13911600000	37569400000	15228400000	15228400000
23888400000	71599600000	215297896111	252.62

			12.16
13.86	44.97	47.94	12.93
14.18	24.67	25.67

Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. Its brands include Eritel, Glimsave, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The firm markets and distributes pharmaceutical drugs, such as tablets, syrups and injections. The company was founded by Amit Indubhushan Bakshi on January 25, 2007 and is headquartered in Ahmedabad, India.

： http://www.eris.co.in

：Amit Indubhushan Bakshi

：2007

：Ahmedabad

：Health technology

：Pharmaceuticals: major